Delve into the current state of prescription digital therapeutics (PDTs) adoption and uncover strategies for increasing payer approval and achieving widespread coverage of PDTs.
New Research Suggest Benefits of Telehealth BCBT for Treating Suicidal Thoughts, Mitigating Attempts
November 12th 2024Researchers evaluated the lesser-known impact of telehealth treatments, including brief cognitive behavioral therapy (BCBT), to address the needs of individuals at risk of or recovering from suicidal ideation.
Read More
Adapting Cancer Treatment for Survivorship and Precision Care
November 7th 2024The American Journal of Managed Care® and Vanderbilt University Medical Center partnered on a recent Institute for Value-Based Medicine® event, which had the theme, “Bringing the Future to the Present in Cancer Care.”
Read More
Proactive Care Management of AI-Identified At-Risk Patients Decreases Preventable Admissions
Proactive care management for artificial intelligence (AI)–identified at-risk patients reduced potentially preventable hospital admissions.
Read More
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: October 21st 2024 | Updated: October 24th 2024Examining care transitions in hospitalized patients revealed lower diagnostic error rates compared with traditional methods, highlighting the effectiveness of this approach in identifying diagnostic challenges.
Read More
FDA Approves Optune Lua Device in NSCLC
October 16th 2024Optune Lua creates tumor-treating fields to disrupt cancer cell division, and it is used in conjunction with PD-1/PD-L1 inhibitors or docetaxel to treat metastatic non–small cell lung cancer (NSCLC) that has not responded to platinum-based treatment.
Read More
Experts Highlight AI's Potential to Enhance ILD Diagnostic Accuracy Amid Limitations
October 7th 2024Experts at the CHEST 2024 annual meeting agreed that artificial intelligence (AI) should not be relied upon entirely, but instead be used as a tool by radiologists to make a diagnosis of interstitial lung disease (ILD).
Read More
Bridging Global Treatment Gaps in Relapsed Multiple Myeloma
September 17th 2024The principal goal of therapies for multiple myeloma, which remains incurable, is to extend progression-free survival, but challenges remain bringing chimeric antigen receptor T-cell therapy to the world, explains Leland Metheny, MD, lead investigator for the phase 1 BAFF CAR T clinical trial, University Hospitals Seidman Cancer Center.
Read More
Liquid Biopsy Advances: Vital Role in Biomarker Testing in Lung Cancer
September 16th 2024Here we conclude our discussion with David P. Carbone, MD, PhD, The Ohio State University, by addressing the importance of both advocacy for and education on biomarker testing in the lung cancer space.
Read More
Leveraging Predictive Analytics to Target Payer-Led Medication Adherence Interventions
September 16th 2024This article explores how payers can enhance their medication adherence initiatives to reduce costs and improve member health outcomes by leveraging predictive analytics through machine learning.
Read More
Evolving Trends in AI: Ensuring Safe and Accurate AI Use in Oncology Care
September 16th 2024The evolving landscape of artificial intelligence (AI) use in cancer care requires evaluation of algorithms before implementation and continual monitoring after, explained Amy Abernethy, MD, cofounder of Highlander Health and former FDA official.
Read More